Asia Pacific Smart Pills Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Application (Capsule Endoscopy, Drug Delivery, and Patient Monitoring), Disease Indication (Gastrointestinal Diseases, Neurological Disorders, Cancer, Inherited Disorders, and Other Disease Indications), and End User (Hospitals and Clinics, Research Institutes, and Home Healthcare) 

The Asia Pacific smart pills market is expected to reach US$ 1,156.22 million by 2028 from US$ 488.75 million in 2021. The market is estimated to grow at a CAGR of 13.1% from 2021 to 2028.

There is a surge in demand for drug delivery systems with fundamental benefits, such as minimal side/adverse effects, targeted drug delivery, optimal use of API, and reduced dosage frequency. This has further resulted in integrating innovative drugs, advanced technologies, and medical devices into drug delivery systems to develop smart pills. People suffering from chronic diseases who need a specific dose of medication are likely to target the patient base for smart pills. The companies have offered various promotional activities, such as product launches, investments, and acquisitions. For instance, in 2019, Otsuka (Proteus) launched smart chemotherapy pills to improve cancer patients' outcomes. In 2019, Stanley Black & Decker and Pillo Health launched a pill-dispensing robot companion. It has been designed to help patients with chronic conditions maintain their medication schedule and health with the help of a built-in voice assistant to communicate with caregivers and patients. Smart pills technologies provide revolutionary advancements for life science research applications. Thus, the increasing demand for drug delivery systems in emerging economies is likely to fuel the growth of the smart pills market during the forecast period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the smart pills market. Asia Pacific smart pills market is expected to grow at a good CAGR during the forecast period.

Asia Pacific Smart Pills Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Smart Pills Market Segmentation  

The Asia Pacific smart pills market is segmented based on application, disease indication, and end user.Based on application, the market is segmented into capsule endoscopy, drug delivery, and patient monitoring. The capsule endoscopy segment is sub segmented into small bowel video capsule endoscopy, colon capsule endoscopy, controllable capsule endoscopy, storable capsule endoscopy, and other capsule endoscopy. Based on disease indication, the market is segmented into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications. Based on end user, the market is segmented into hospitals and clinics, research institutes, and home healthcare. By Country, the Asia Pacific smart pills market is segmented into Japan, China, India, South Korea, Australia, and the Rest of APAC.

Asia Pacific Smart Pills Market – Companies Mentioned

Medtronic; PENTAX Medical; Olympus Corporation; Otsuka Holdings Co., Ltd.; IntroMedic Co., Ltd; JINSHAN Science & Technology; and RF Co., Ltd are among the leading companies in the Asia Pacific smart pills market.

1. Medtronic                    
2. PENTAX Medical                
3. Olympus Corporation                
4. Otsuka Holdings Co., Ltd.            
5. IntroMedic Co., Ltd                
6. JINSHAN Science & Technology            
7. RF Co., Ltd  

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Smart Pills Market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific Smart Pills Market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.